{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["COVID-19", "HLA", "Prognosis"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36718139", "DateRevised": {"Year": "2023", "Month": "02", "Day": "02"}, "Article": {"ArticleDate": [{"Year": "2023", "Month": "01", "Day": "26"}], "Language": ["eng"], "ELocationID": ["14", "10.1186/s43042-023-00392-3"], "Journal": {"ISSN": "2090-2441", "JournalIssue": {"Volume": "24", "Issue": "1", "PubDate": {"Year": "2023"}}, "Title": "The Egyptian journal of medical human genetics", "ISOAbbreviation": "Egypt J Med Hum Genet"}, "ArticleTitle": "The role of HLA genotypes in understanding the pathogenesis of severe COVID-19.", "Pagination": {"StartPage": "14", "MedlinePgn": "14"}, "Abstract": {"AbstractText": ["The coronavirus disease 2019 (COVID-19) pandemic has caused human tragedy through the global spread of the viral pathogen SARS-CoV-2. Although the underlying factors for the severity of COVID-19 in different people are still unknown, several gene variants can be used as predictors of disease severity, particularly variations in viral receptor genes such as angiotensin-converting enzyme 2 (ACE2) or major histocompatibility complex (MHC) genes. The reaction of the immune system, as the most important defense strategy in the case of viruses, plays a decisive role. The innate immune system is important both as a primary line of defense and as a trigger of the acquired immune response. The HLA-mediated acquired immune response is linked to the acquired immune system. In various diseases, it has been shown that genetic alterations in components of the immune system can play a crucial role in how the body responds to pathogens, especially viruses. One of the most important host genetic factors is the human leukocyte antigen (HLA) profile, which includes HLA classes I and II and may be symbolic of the diversity of immune response and genetic predisposition in disease progression. COVID-19 will have direct contact with the acquired immune system as an intracellular pathogen after exposure to the proteasome and its components through class I HLA. Therefore, it is assumed that in different genotypes of the HLA-I class, an undesirable supply causes an insufficient activation of the immune system. Insufficient binding of antigen delivered by class I HLA to host lymphocytes results in uncertain identification and insufficient activation of the acquired immune system. The absence of secretion of immune cytokines such as interferons, which play an important role in controlling viral infection in the early stages, is a complication of this event. Understanding the allelic diversity of HLA in people infected with coronavirus compared with uninfected people of one race not only allows identification of people with HLA susceptible to COVID-19 but also provides better insight into the behavior of the virus, which helps to take effective preventive and curative measures earlier."], "CopyrightInformation": "\u00a9 The Author(s) 2023."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": ["grid.411583.a", "0000 0001 2198 6209"], "Affiliation": "Medical Genetics and Molecular Medicine Department, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Arab", "ForeName": "Fatemeh", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["grid.464653.6", "0000 0004 0459 3173"], "Affiliation": "Natural Products and Medicinal Plants Research Center, North Khorasan University of Medical Sciences, Bojnurd, Iran."}], "LastName": "Mollazadeh", "ForeName": "Samaneh", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["grid.411301.6", "0000 0001 0666 1211"], "Affiliation": "Department of Biology, Faculty of Sciences, University of Ferdowsi, Mashhad, Iran."}], "LastName": "Ghayourbabaei", "ForeName": "Farnaz", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": ["grid.411583.a", "0000 0001 2198 6209"], "Affiliation": "Medical Genetics and Molecular Medicine Department, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Moghbeli", "ForeName": "Meysam", "Initials": "M"}, {"Identifier": ["0000-0002-1679-1068"], "AffiliationInfo": [{"Identifier": ["grid.411583.a", "0000 0001 2198 6209"], "Affiliation": "Medical Genetics and Molecular Medicine Department, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Saburi", "ForeName": "Ehsan", "Initials": "E"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Egypt", "MedlineTA": "Egypt J Med Hum Genet", "NlmUniqueID": "101151137", "ISSNLinking": "1110-8630"}, "CoiStatement": "Competing interestsThe authors declare that they have no competing interests."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Jackson CB, Farzan M, Chen B, Choe H. Mechanisms of SARS-CoV-2 entry into cells. Nat Rev Mol Cell Biol. 2022;23(1):3\u201320. doi: 10.1038/s41580-021-00418-x.", "ArticleIdList": ["10.1038/s41580-021-00418-x", "PMC8491763", "34611326"]}, {"Citation": "Ranga V, Niemel\u00e4 E, Tamirat MZ, Eriksson JE, Airenne TT, Johnson MS. Immunogenic SARS-CoV-2 epitopes: In silico study towards better understanding of COVID-19 disease\u2014paving the way for vaccine development. Vaccines. 2020;8(3):408. doi: 10.3390/vaccines8030408.", "ArticleIdList": ["10.3390/vaccines8030408", "PMC7564651", "32717854"]}, {"Citation": "Costela-Ruiz VJI-MR, Puerta-Puerta JM, Ruiz C, Melguizo-Rodr\u00edguez L. SARS-CoV-2, 2020. itrociC-dCGFR.", "ArticleIdList": ["PMC7265853", "32513566"]}, {"Citation": "Xu Z, Shi L, Wang Y, Zhang J, Huang L, Zhang C, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med. 2020;8(4):420\u2013422. doi: 10.1016/S2213-2600(20)30076-X.", "ArticleIdList": ["10.1016/S2213-2600(20)30076-X", "PMC7164771", "32085846"]}, {"Citation": "Saburi E, Abazari MF, Hassannia H, Mansour RN, Eshaghi-Gorji R, Gheibi M, et al. The use of mesenchymal stem cells in the process of treatment and tissue regeneration after recovery in patients with Covid-19. Gene. 2021;777:145471. doi: 10.1016/j.gene.2021.145471.", "ArticleIdList": ["10.1016/j.gene.2021.145471", "PMC7860931", "33549712"]}, {"Citation": "Singh SP, Pritam M, Pandey B, Yadav TP. Microstructure, pathophysiology, and potential therapeutics of COVID-19: a comprehensive review. J Med Virol. 2020;5:99.", "ArticleIdList": ["PMC7361355", "32617987"]}, {"Citation": "Abdelghany T, Ganash M, Bakri MM, Qanash H, Al-Rajhi AM, Elhussieny NI. SARS-CoV-2, the other face to SARS-CoV and MERS-CoV: future predictions. Biomed J. 2021;44(1):86\u201393. doi: 10.1016/j.bj.2020.10.008.", "ArticleIdList": ["10.1016/j.bj.2020.10.008", "PMC7603957", "33602634"]}, {"Citation": "Teymouri M, Mollazadeh S, Mortazavi H, Ghale-Noie ZN, Keyvani V, Aghababaei F, et al. Recent advances and challenges of RT-PCR tests for the diagnosis of COVID-19. Pathol-Res Pract. 2021;221:153443. doi: 10.1016/j.prp.2021.153443.", "ArticleIdList": ["10.1016/j.prp.2021.153443", "PMC8045416", "33930607"]}, {"Citation": "Xu X, Chen P, Wang J, Feng J, Zhou H, Li X, et al. Evolution of the novel coronavirus from the ongoing Wuhan outbreak and modeling of its spike protein for risk of human transmission. Sci China Life Sci. 2020;63(3):457\u2013460. doi: 10.1007/s11427-020-1637-5.", "ArticleIdList": ["10.1007/s11427-020-1637-5", "PMC7089049", "32009228"]}, {"Citation": "https://www.hsph.harvard.edu/news/hsph-in-the-news/the-latest-on-the-coronavirus/."}, {"Citation": "Saha A, Sharma AR, Bhattacharya M, Sharma G, Lee S-S, Chakraborty C. Tocilizumab: a therapeutic option for the treatment of cytokine storm syndrome in COVID-19. Arch Med Res. 2020;51(6):595\u2013597. doi: 10.1016/j.arcmed.2020.05.009.", "ArticleIdList": ["10.1016/j.arcmed.2020.05.009", "PMC7241374", "32482373"]}, {"Citation": "https://www.who.int/news/item/17-05-2022-statement-for-healthcare-professionals-how-covid-19-vaccines-are-regulated-for-safety-and-effectiveness."}, {"Citation": "Rosendahl Huber S, van Beek J, de Jonge J, Luytjes W, van Baarle D. T cell responses to viral infections\u2013opportunities for peptide vaccination. Front Immunol. 2014;5:171. doi: 10.3389/fimmu.2014.00171.", "ArticleIdList": ["10.3389/fimmu.2014.00171", "PMC3997009", "24795718"]}, {"Citation": "Shang J, Wan Y, Luo C, Ye G, Geng Q, Auerbach A, et al. Cell entry mechanisms of SARS-CoV-2. Proc Natl Acad Sci. 2020;117(21):11727\u201311734. doi: 10.1073/pnas.2003138117.", "ArticleIdList": ["10.1073/pnas.2003138117", "PMC7260975", "32376634"]}, {"Citation": "Atabati H, Yazdanpanah E, Mortazavi H, Raoofi A, Esmaeili S-A, Khaledi A, et al. Immunoregulatory effects of tolerogenic probiotics in multiple sclerosis. Rev New Drug Targets Age-Related Disord. 2021;8:87\u2013105. doi: 10.1007/978-3-030-55035-6_6.", "ArticleIdList": ["10.1007/978-3-030-55035-6_6", "33725347"]}, {"Citation": "Coperchini F, Chiovato L, Croce L, Magri F, Rotondi M. The cytokine storm in COVID-19: an overview of the involvement of the chemokine/chemokine-receptor system. Cytokine Growth Factor Rev. 2020;8:64.", "ArticleIdList": ["PMC7211650", "32446778"]}, {"Citation": "Costela-Ruiz VJ, Illescas-Montes R, Puerta-Puerta JM, Ruiz C, Melguizo-Rodr\u00edguez L. SARS-CoV-2 infection: the role of cytokines in COVID-19 disease. Cytokine Growth Factor Rev. 2020;6:87.", "ArticleIdList": ["PMC7265853", "32513566"]}, {"Citation": "Saha A, Sharma AR, Bhattacharya M, Sharma G, Lee S-S, Chakraborty C. Tocilizumab: a therapeutic option for the treatment of cytokine storm syndrome in COVID-19. Arch Med Res. 2020;6:14.", "ArticleIdList": ["PMC7241374", "32482373"]}, {"Citation": "Zangouei AS, Hamidi AA, Rahimi HR, Saburi E, Mojarrad M, Moghbeli M. Chemokines as the critical factors during bladder cancer progression: an overview. Int Rev Immunol. 2021;40(5):344\u2013358. doi: 10.1080/08830185.2021.1877287.", "ArticleIdList": ["10.1080/08830185.2021.1877287", "33591855"]}, {"Citation": "Coperchini F, Chiovato L, Croce L, Magri F, Rotondi M. The cytokine storm in COVID-19: an overview of the involvement of the chemokine/chemokine-receptor system. Cytokine Growth Factor Rev. 2020;53:25\u201332. doi: 10.1016/j.cytogfr.2020.05.003.", "ArticleIdList": ["10.1016/j.cytogfr.2020.05.003", "PMC7211650", "32446778"]}, {"Citation": "Zhang C, Wu Z, Li J-W, Zhao H, Wang G-Q. Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality. Int J Antimicrob Agents. 2020;55(5):105954. doi: 10.1016/j.ijantimicag.2020.105954.", "ArticleIdList": ["10.1016/j.ijantimicag.2020.105954", "PMC7118634", "32234467"]}, {"Citation": "Brocker C, Thompson D, Matsumoto A, Nebert DW, Vasiliou V. Evolutionary divergence and functions of the human interleukin (IL) gene family. Hum Genom. 2010;5(1):30. doi: 10.1186/1479-7364-5-1-30.", "ArticleIdList": ["10.1186/1479-7364-5-1-30", "PMC3390169", "21106488"]}, {"Citation": "Ovsyannikova IG, Haralambieva IH, Crooke SN, Poland GA, Kennedy RB. The role of host genetics in the immune response to SARS-CoV-2 and COVID-19 susceptibility and severity. Immunol Rev. 2020;296(1):205\u2013219. doi: 10.1111/imr.12897.", "ArticleIdList": ["10.1111/imr.12897", "PMC7404857", "32658335"]}, {"Citation": "Weider T, Richardson SJ, Morgan NG, Paulsen TH, Dahl-J\u00f8rgensen K, Hammerstad SS. HLA class I upregulation and antiviral immune responses in graves disease. J Clin Endocrinol Metab. 2021;106(4):e1763\u2013e1774. doi: 10.1210/clinem/dgaa958.", "ArticleIdList": ["10.1210/clinem/dgaa958", "PMC7993595", "33367784"]}, {"Citation": "Mobini Kesheh M, Shavandi S, Hosseini P, Kakavand-Ghalehnoei R, Keyvani H. Bioinformatic HLA studies in the context of SARS-CoV-2 pandemic and review on association of HLA alleles with preexisting medical conditions. BioMed Res Int. 2021;2:21.", "ArticleIdList": ["PMC8162251", "34136572"]}, {"Citation": "Nguyen A, David JK, Maden SK, Wood MA, Weeder BR, Nellore A, et al. Human leukocyte antigen susceptibility map for SARS-CoV-2. J Virol. 2020;6:41.", "ArticleIdList": ["PMC7307149", "32303592"]}, {"Citation": "Hamelin DJ, Fournelle D, Grenier J-C, Schockaert J, Kovalchik K, Kubiniok P, et al. The mutational landscape of SARS-CoV-2 variants diversifies T cell targets in an HLA supertype-dependent manner. bioRxiv. 2021;9:417.", "ArticleIdList": ["PMC8492600", "34637888"]}, {"Citation": "Ghale-Noie ZN, Salmaninejad A, Bergquist R, Mollazadeh S, Hoseini B, Sahebkar A. Genetic aspects and immune responses in Covid-19: important organ involvement. Identif Biomarkers New Treat Vaccines COVID-19. 2021;5:3\u201322. doi: 10.1007/978-3-030-71697-4_1.", "ArticleIdList": ["10.1007/978-3-030-71697-4_1", "34279825"]}, {"Citation": "Medina-Enr\u00edquez MM, Lopez-Le\u00f3n S, Carlos-Escalante JA, Aponte-Torres Z, Cuapio A, Wegman-Ostrosky T. ACE2: the molecular doorway to SARS-CoV-2. Cell Biosci. 2020;10(1):1\u201317. doi: 10.1186/s13578-020-00519-8.", "ArticleIdList": ["10.1186/s13578-020-00519-8", "PMC7772801", "33380340"]}, {"Citation": "Liu PP, Blet A, Smyth D, Li H. The science underlying COVID-19: implications for the cardiovascular system. Circulation. 2020;142(1):68\u201378. doi: 10.1161/CIRCULATIONAHA.120.047549.", "ArticleIdList": ["10.1161/CIRCULATIONAHA.120.047549", "32293910"]}, {"Citation": "Forouzesh M, Rahimi A, Valizadeh R, Dadashzadeh N, Mirzazadeh A. Clinical display, diagnostics and genetic implication of Novel coronavirus (COVID-19) epidemic. Eur Rev Med Pharmacol Sci. 2020;24:4607\u20134615.", "ArticleIdList": ["32374001"]}, {"Citation": "Patarroyo ME, Patarroyo MA, Alba MP, Pabon L, Rugeles MT, Aguilar-Jimenez W, et al. The first chemically-synthesised, highly immunogenic anti-SARS-CoV-2 peptides in DNA genotyped aotus monkeys for human use. Front Immunol. 2021;12:724060. doi: 10.3389/fimmu.2021.724060.", "ArticleIdList": ["10.3389/fimmu.2021.724060", "PMC8446425", "34539660"]}, {"Citation": "Naemi FM, Al-adwani S, Al-khatabi H, Al-nazawi A. Association between the HLA genotype and the severity of COVID-19 infection among South Asians. J Med Virol. 2021;93(7):4430\u20134437. doi: 10.1002/jmv.27003.", "ArticleIdList": ["10.1002/jmv.27003", "PMC8251353", "33830530"]}, {"Citation": "Saulle I, Vicentini C, Clerici M, Biasin M. Antigen presentation in SARS-CoV-2 infection: the role of class I HLA and ERAP polymorphisms. Hum Immunol. 2021;82(8):551\u2013560. doi: 10.1016/j.humimm.2021.05.003.", "ArticleIdList": ["10.1016/j.humimm.2021.05.003", "PMC8108382", "34116863"]}, {"Citation": "D\u2019amico S, Tempora P, Lucarini V, Melaiu O, Gaspari S, Algeri M, et al. ERAP1 and ERAP2 enzymes: a protective shield for RAS against COVID-19? Int J Mol Sci. 2021;22(4):1705. doi: 10.3390/ijms22041705.", "ArticleIdList": ["10.3390/ijms22041705", "PMC7914632", "33567739"]}, {"Citation": "Saulle I, Vicentini C, Clerici M, Biasin M. Antigen presentation in SARS-CoV-2 infection: the role of class I HLA and ERAP polymorphisms. Hum Immunol. 2021;8:47.", "ArticleIdList": ["PMC8108382", "34116863"]}, {"Citation": "MacDonald KS, Fowke KR, Kimani J, Dunand VA, Nagelkerke NJ, Blake Ball T, et al. Influence of HLA supertypes on susceptibility and resistance to human immunodeficiency virus type 1 infection. J Infect Dis. 2000;181(5):1581\u20131589. doi: 10.1086/315472.", "ArticleIdList": ["10.1086/315472", "10823757"]}, {"Citation": "Stephens H, Klaythong R, Sirikong M, Vaughn D, Green S, Kalayanarooj S, et al. HLA-A and-B allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic Thais. Tissue Antigens. 2002;60(4):309\u2013318. doi: 10.1034/j.1399-0039.2002.600405.x.", "ArticleIdList": ["10.1034/j.1399-0039.2002.600405.x", "12472660"]}, {"Citation": "Barquera R, Collen E, Di D, Buhler S, Teixeira J, Llamas B, et al. Binding affinities of 438 HLA proteins to complete proteomes of seven pandemic viruses and distributions of strongest and weakest HLA peptide binders in populations worldwide. HLA. 2020;8:948.", "ArticleIdList": ["PMC7300650", "32475052"]}, {"Citation": "Keicho N, Itoyama S, Kashiwase K, Phi NC, Long HT, Van Ban V, et al. Association of human leukocyte antigen class II alleles with severe acute respiratory syndrome in the Vietnamese population. Hum Immunol. 2009;70(7):527\u2013531. doi: 10.1016/j.humimm.2009.05.006.", "ArticleIdList": ["10.1016/j.humimm.2009.05.006", "PMC7132661", "19445991"]}, {"Citation": "Lin M, Tseng H-K, Trejaut JA, Lee H-L, Loo J-H, Chu C-C, et al. Association of HLA class I with severe acute respiratory syndrome coronavirus infection. BMC Med Genet. 2003;4(1):9. doi: 10.1186/1471-2350-4-9.", "ArticleIdList": ["10.1186/1471-2350-4-9", "PMC212558", "12969506"]}, {"Citation": "Ng MH, Lau K-M, Li L, Cheng S-H, Chan WY, Hui PK, et al. Association of human-leukocyte-antigen class I (B* 0703) and class II (DRB1* 0301) genotypes with susceptibility and resistance to the development of severe acute respiratory syndrome. J Infect Dis. 2004;190(3):515\u2013518. doi: 10.1086/421523.", "ArticleIdList": ["10.1086/421523", "PMC7109646", "15243926"]}, {"Citation": "Correale P, Mutti L, Pentimalli F, Baglio G, Saladino RE, Sileri P, et al. HLA-B* 44 and C* 01 prevalence correlates with Covid19 spreading across Italy. Int J Mol Sci. 2020;21(15):5205. doi: 10.3390/ijms21155205.", "ArticleIdList": ["10.3390/ijms21155205", "PMC7432860", "32717807"]}, {"Citation": "Wang W, Zhang W, Zhang J, He J, Zhu F. Distribution of HLA allele frequencies in 82 Chinese individuals with coronavirus disease-2019 (COVID-19) Hla. 2020;2:78.", "ArticleIdList": ["PMC7276866", "32424945"]}, {"Citation": "Warren RL, Birol I. HLA predictions from the bronchoalveolar lavage fluid samples of five patients at the early stage of the Wuhan seafood market COVID-19 outbreak. ArXiv. 2020;9:56."}, {"Citation": "Tomita Y, Ikeda T, Sato R, Sakagami T. Association between HLA gene polymorphisms and mortality of COVID-19: an in silico analysis. Immun Inflamm Dis. 2020;8(4):684\u2013694. doi: 10.1002/iid3.358.", "ArticleIdList": ["10.1002/iid3.358", "PMC7654404", "33047883"]}, {"Citation": "Yung YL, Cheng CK, Chan HY, Xia JT, Lau KM, Wong RS, et al. Association of HLA-B22 serotype with SARS-CoV-2 susceptibility in Hong Kong Chinese patients. Hla. 2021;97(2):127\u2013132. doi: 10.1111/tan.14135.", "ArticleIdList": ["10.1111/tan.14135", "PMC7898481", "33179437"]}, {"Citation": "Toyoshima Y, Nemoto K, Matsumoto S, Nakamura Y, Kiyotani K. SARS-CoV-2 genomic variations associated with mortality rate of COVID-19. J Hum Genet. 2020;5:1\u20138.", "ArticleIdList": ["PMC7375454", "32699345"]}, {"Citation": "Pisanti S, Deelen J, Gallina AM, Caputo M, Citro M, Abate M, et al. Correlation of the two most frequent HLA haplotypes in the Italian population to the differential regional incidence of Covid-19. J Transl Med. 2020;18(1):1\u201316. doi: 10.1186/s12967-020-02515-5.", "ArticleIdList": ["10.1186/s12967-020-02515-5", "PMC7491019", "32933522"]}, {"Citation": "Novelli A, Andreani M, Biancolella M, Liberatoscioli L, Passarelli C, Colona VL, et al. HLA allele frequencies and susceptibility to COVID-19 in a group of 99 Italian patients. Hla. 2020;96(5):610\u2013614. doi: 10.1111/tan.14047.", "ArticleIdList": ["10.1111/tan.14047", "PMC7461491", "32827207"]}, {"Citation": "Iturrieta-Zuazo I, Rita CG, Garc\u00eda-Soid\u00e1n A, de Malet P-F, Alonso-Alarc\u00f3n N, Pariente-Rodr\u00edguez R, et al. Possible role of HLA class-I genotype in SARS-CoV-2 infection and progression: a pilot study in a cohort of Covid-19 Spanish patients. Clin Immunol. 2020;219:108572. doi: 10.1016/j.clim.2020.108572.", "ArticleIdList": ["10.1016/j.clim.2020.108572", "PMC7428760", "32810602"]}, {"Citation": "Group SC-G. Genomewide association study of severe Covid-19 with respiratory failure. New England J Med. 2020;383(16):1522\u201334. doi: 10.1056/NEJMoa2020283.", "ArticleIdList": ["10.1056/NEJMoa2020283", "PMC7315890", "32558485"]}, {"Citation": "Lorente L, Mart\u00edn MM, Franco A, Barrios Y, C\u00e1ceres JJ, Sol\u00e9-Viol\u00e1n J, et al. HLA genetic polymorphisms and prognosis of patients with COVID-19. Med Intensiva. 2021;45(2):96\u2013103. doi: 10.1016/j.medin.2020.08.004.", "ArticleIdList": ["10.1016/j.medin.2020.08.004", "PMC7905376", "32988645"]}, {"Citation": "Sakuraba A, Haider H, Sato T. Population difference in allele frequency of HLA-C* 05 and its correlation with COVID-19 mortality. Viruses. 2020;12(11):1333. doi: 10.3390/v12111333.", "ArticleIdList": ["10.3390/v12111333", "PMC7699862", "33233780"]}, {"Citation": "Littera R, Campagna M, Deidda S, Angioni G, Cipri S, Melis M, et al. Human leukocyte antigen complex and other immunogenetic and clinical factors influence susceptibility or protection to SARS-CoV-2 infection and severity of the disease course. Sardinian Exp Front Immunol. 2020;11:3320.", "ArticleIdList": ["PMC7746644", "33343579"]}, {"Citation": "Abdelhafiz AS, Ali A, Fouda MA, Sayed DM, Kamel MM, Kamal LM, et al. HLA-B* 15 predicts survival in Egyptian patients with COVID-19. Hum Immunol. 2022;83(1):10\u201316. doi: 10.1016/j.humimm.2021.09.007.", "ArticleIdList": ["10.1016/j.humimm.2021.09.007", "PMC8485223", "34607724"]}, {"Citation": "Shkurnikov M, Nersisyan S, Jankevic T, Galatenko A, Gordeev I, Vechorko V, et al. Association of HLA class I genotypes with severity of coronavirus disease-19. Front Immunol. 2021;12:641900. doi: 10.3389/fimmu.2021.641900.", "ArticleIdList": ["10.3389/fimmu.2021.641900", "PMC7959787", "33732261"]}, {"Citation": "Anzurez A, Naka I, Miki S, Nakayama-Hosoya K, Isshiki M, Watanabe Y, et al. Association of HLA-DRB1* 09: 01 with severe COVID-19. Hla. 2021;98(1):37\u201342. doi: 10.1111/tan.14256.", "ArticleIdList": ["10.1111/tan.14256", "PMC8251239", "33734601"]}, {"Citation": "Weiner J, 3rd, Suwalski P, Holtgrewe M, Rakitko A, Thibeault C, M\u00fcller M, et al. Increased risk of severe clinical course of COVID-19 in carriers of HLA-C* 04: 01. EClinicalMedicine. 2021;40:101099. doi: 10.1016/j.eclinm.2021.101099.", "ArticleIdList": ["10.1016/j.eclinm.2021.101099", "PMC8410317", "34490415"]}, {"Citation": "Langton DJ, Bourke SC, Lie BA, Reiff G, Natu S, Darlay R, et al. The influence of HLA genotype on the severity of COVID-19 infection. Hla. 2021;98(1):14\u201322. doi: 10.1111/tan.14284.", "ArticleIdList": ["10.1111/tan.14284", "PMC8251294", "33896121"]}, {"Citation": "Romero-Lopez JP, Carnalla-Cortes M, Pacheco-Olvera DL, Ocampo-Godinez JM, Oliva-Ramirez J, Moreno-Manjon J, et al. A bioinformatic prediction of antigen presentation from SARS-CoV-2 spike protein revealed a theoretical correlation of HLA-DRB1* 01 with COVID-19 fatality in Mexican population: an ecological approach. J Med Virol. 2021;93(4):2029\u20132038. doi: 10.1002/jmv.26561.", "ArticleIdList": ["10.1002/jmv.26561", "PMC7537233", "32986250"]}, {"Citation": "Warren RL, Birol I. HLA alleles measured from COVID-19 patient transcriptomes reveal associations with disease prognosis in a New York cohort. PeerJ. 2021;9:e12368. doi: 10.7717/peerj.12368.", "ArticleIdList": ["10.7717/peerj.12368", "PMC8522641", "34722002"]}, {"Citation": "Wang WZW, Zhang J, He J, Zhu F. Distribution of HLA allele frequencies in 82 Chinese individuals with coronavirus disease-2019 (COVID-19) Hla. 2020;8:42.", "ArticleIdList": ["PMC7276866", "32424945"]}, {"Citation": "Lorente L, Mart\u00edn M, Franco A, Barrios Y, C\u00e1ceres J, Sol\u00e9-Viol\u00e1n J, et al. HLA genetic polymorphisms and prognosis of patients with COVID-19. Med Intensiva. 2021;45(2):96\u2013103. doi: 10.1016/j.medin.2020.08.004.", "ArticleIdList": ["10.1016/j.medin.2020.08.004", "PMC7905376", "32988645"]}, {"Citation": "Correale P, Mutti L, Pentimalli F, Baglio G, Saladino RE, Sileri P, et al. HLA-B*44 and C*01 prevalence correlates with Covid19 spreading across Italy. Int J Mol Sci. 2020;21(15):87. doi: 10.3390/ijms21155205.", "ArticleIdList": ["10.3390/ijms21155205", "PMC7432860", "32717807"]}, {"Citation": "Littera R, Campagna M, Deidda S, Angioni G, Cipri S, Melis M et al (2020) Human leukocyte antigen complex and other immunogenetic and clinical factors influence susceptibility or protection to SARS-CoV-2 infection and severity of the disease course. Sardinian Exper Front Immunol 11:605688", "ArticleIdList": ["PMC7746644", "33343579"]}, {"Citation": "Esmaeili A, Rabe SZT, Mahmoudi M, Rastin M (2017) Frequencies of HLA-A, B and DRB1 alleles in a large normal population living in the city of Mashhad, Northeastern Iran. Iran J Basic Med Sci. 2017;20(8):940\u2013943. 10.22038/IJBMS.2017.9117.", "ArticleIdList": ["PMC5651480", "29085586"]}, {"Citation": "Mobasheri L, Nasirpour MH, Masoumi E, Azarnaminy AF, Jafari M, Esmaeili SA (2022) SARS-CoV-2 triggering autoimmune diseases. Cytokine. 2022;154:155873. 10.1016/j.cyto.2022.155873.", "ArticleIdList": ["PMC8979824", "35461172"]}, {"Citation": "Saburi E, Abazari MF, Hassannia H, Mansour RN, Eshaghi-Gorji R, Gheibi M, Rahmati M, Enderami SE (2021) The use of mesenchymal stem cells in the process of treatment and tissue regeneration after recovery in patients with Covid-19. Gene. 2021;777:145471. 10.1016/j.gene.2021.145471.", "ArticleIdList": ["PMC7860931", "33549712"]}, {"Citation": "Arab F, Jafari Rad M, Esmaeili S, Mirhosseini A, Moharreri M, Saburi E (2022) Investigation of polymorphisms of ACEII gene in people with coronavirus with severe and mild symptoms or asymptomatic. Int J Travel Med Global Health 10(3):122\u2013126. 10.34172/ijtmgh.2022.22."}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "7", "Day": "6"}, {"Year": "2023", "Month": "1", "Day": "18"}, {"Year": "2023", "Month": "1", "Day": "31", "Hour": "1", "Minute": "43"}, {"Year": "2023", "Month": "2", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "2", "Day": "1", "Hour": "6", "Minute": "1"}, {"Year": "2023", "Month": "1", "Day": "26"}], "PublicationStatus": "ppublish", "ArticleIdList": ["36718139", "PMC9878497", "10.1186/s43042-023-00392-3", "392"]}}], "PubmedBookArticle": []}